PROFESSOR DR ISHAK SULIAMAN is currently a Head Department of Al-Quran and Al-Hadith at Academy of Islamic Studies, University of Malaya and a Professor in the field of the Hadith Studies. He is a Chief Editor of Journal al-Bayan of which is indexed by Web of Science, Scopus and published by Brill Publishers. He received his Ph.D degree from The University of Wales, Lampeter UK in 2005 in the field of Hadith Muamalah. His interest also in Digital Hadith and Psycho Spiritual of Sunnah. In 2013, he awarded as a Visiting Researcher at Islamic University of Medinah, Saudi Arabia. He served as Director for the Department of Malaysian Studies, Cairo University, Egypt from the 1st January 2016 until the end of December 2018. Prior to that, he was a Deputy Director for Postgraduate Studies at Academy of Islamic Studies, UM from 2009 to 2011. He was also served as Acting Deputy Director for R&D at Academy of Islamic Studies, UM from September 2011 to January 2013. He was also served the country as a Deputy Chairman of Lajnah Tahqiq Hadith KDN (Hadith Review and Assessment Committee under the purview of the Home Ministry of Malaysia from 2019 to December 2022. He also serves as external accessor for Bachelor Degree of Al-Quran and Al-Sunnah of Universiti Sains Islam Malaysia (USIM). For Non-Governmental Organisation (NGO), he had served as Secretary General of Muslim Scholars Association of Malaysia in 2000. Besides, he served as a President of Muafakat for MRSM Ulul Albab, Negeri Sembilan in 2010 and as a Deputy President of Alumni Association of Academy of Islamic Studies, University of Malaya. In terms of academic experiences, he received UMRG (University Malaya Research Grant) as a Project Leader for research project entitles ‘Preserving The Authenticity of The Digital Hadith’ in 2014 and completed in 2017. One of the outcomes for this project is android application namely ‘Digitalhadith’. This project awarded 1 Gold and 1 Silver in 2018 and 2019 at International Competition of Ideas, Inventions and Innovations (i-Fame) organised by UiTM. He has an ongoing collaboration research projects of Fundamental Research Grant (FRGS) in the field of Waqf of Infrastructure and in the field of Astrometry of Prayer Times. In 2022, he received Industrial Funding from Rimbunan Islamic Media Sdn.Bhd with the amount RM150,000 as a Project Leader for research project entitles 'Research on Translation of Sahih Muslim'.

DR.-ING Nurdiana Nordin received her B.Sc. (field: Pure Chemistry) under Biasiswa Khas Tenaga Akademik (BKTA) Scholarship from the Ministry of Higher Education, Malaysia in 2012 and her M.Sc. (Field: Organic and Computational Chemistry) under SLAB Scholarship in 2015 from Universiti Malaya, Kuala Lumpur, Malaysia. After graduation, she joined the Institute of Microstructure Technology (IMT) at Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany, in 2016 under the supervision of Dr. Neil MacKinnon and Dr. Vlad Badilita in the group of Prof. Jan G. Korvink. At the same time, she also joined the Bio-Interfaces Graduate International School (BIF-IGS) at the Institut für Biologische Grenzflächen, IBG. She received her PhD degree in 2020 from BIF-IGS and the Faculty of Mechanical Engineering, KIT. In Karlsruhe, she was trained in nuclear magnetic resonance (NMR) technology and clean room fabrication of microfluidic devices. She had extensive laboratory work that included electrochemical systems, microfluidic fabrication processes, bioorganic synthesis, biopolymer surface modification, and the NMR techniques. Her research interests include NMR development, bioorganic mechanisms, biomedical microsystems (BioMEMS - sensor), organ on-a-chip, flexible electronics and metabolomic studies.

Prof. Ali Mohammad Sharifi is a scholar with over 27 years of experience in Molecular Pharmacology at the Iran University of Medical Sciences and currently joined as a professor of regenerative Medicine in the Tissue Engineering Group at NOCERAL, department of Orthopedics Surgery, School of Medicine. He obtained his Ph.D. from the University of Glasgow in 1992 and in 2018, he further enriched his expertise by acquiring a Tissue Banking Diploma from the National University of Singapore. Throughout his career, Prof. Sharifi has undertaken international research, including working at McGill University in Canada and at Max Plank Institute in Germany. His research output includes over 100 publications in high-impact journals, along with several patented innovations. He has held various administrative and editorial roles in academia, and has served as a peer reviewer for numerous high-impact journals. His dedication to education is evident through his mentorship of undergraduate and postgraduate students, particularly Ph.D. candidates specializing in molecular medicine, tissue engineering, molecular pharmacology, and cell therapy.  Prof. Sharifi's research expertise involves the fields of cell therapy and regenerative Pharmacology, with a particular emphasis on translational medicine. His extensive body of work includes pioneering studies on pharmacological priming, therapeutic angiogenesis, and innovative strategies to enhance the effectiveness of stem cell therapy by manipulating HIF-1α stabilization, especially in the context of diabetes. Additionally, his research activities include bone and cartilage regeneration, employing a diverse array of strategies such as stem cells and biologically derived products like amniotic membrane extract and mesenchymal stem cell-derived secretome. He has also explored the potential of herbal agents in regenerative medicine.  His contributions extend to the development of custom-made bio-implants for addressing large bone defects and the design and production of various wound dressings, with a specific focus on diabetic wound healing. In recent times, Prof. Sharifi has harnessed the transformative power of CRISPR gene editing technology to combat synovial fibrosis induced by osteoarthritis. In summary, Professor Sharifi is an active scientist in the field of Molecular Pharmacology and Regenerative Medicine, exemplifying innovation, and dedication to advancing scientific knowledge for improvement of healthcare and human well-being.